LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.215
-0.025 (-2.02%)
May 6, 2025, 12:15 PM EDT - Market open

LAVA Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-25.11-41.87-31.91-42.36-15.93
Upgrade
Depreciation & Amortization
0.470.610.780.560.46
Upgrade
Loss (Gain) From Sale of Investments
-2.64-1.9-0.130.45-
Upgrade
Stock-Based Compensation
3.235.044.113.910.56
Upgrade
Other Operating Activities
0.131.71-2.92-2.040.87
Upgrade
Change in Accounts Receivable
---2.890.78-1.07
Upgrade
Change in Accounts Payable
-1.570.351.411.620.32
Upgrade
Change in Unearned Revenue
--33.51-4.656.18
Upgrade
Change in Other Net Operating Assets
5.95-4.232.0813.09-0.7
Upgrade
Operating Cash Flow
-19.54-40.284.04-28.65-9.31
Upgrade
Capital Expenditures
-0.02-0.73-0.59-0.76-0.5
Upgrade
Sale of Property, Plant & Equipment
0.09----
Upgrade
Investment in Securities
12.41-16.919.93-42.78-
Upgrade
Investing Cash Flow
12.48-17.649.35-43.55-0.5
Upgrade
Long-Term Debt Issued
--0.610.682.03
Upgrade
Long-Term Debt Repaid
-0.6--0.34-0.34-0.24
Upgrade
Net Debt Issued (Repaid)
-0.6-0.270.341.79
Upgrade
Issuance of Common Stock
0.03-0.0294.19-
Upgrade
Financing Cash Flow
-0.57-0.28151.1618.97
Upgrade
Foreign Exchange Rate Adjustments
-1.581.82-4.21-3.92-0.68
Upgrade
Net Cash Flow
-9.22-56.19.4675.058.48
Upgrade
Free Cash Flow
-19.57-41.013.46-29.41-9.81
Upgrade
Free Cash Flow Margin
-163.30%-605.91%17.82%-549.74%-261.78%
Upgrade
Free Cash Flow Per Share
-0.73-1.530.13-1.49-24.58
Upgrade
Cash Income Tax Paid
0.280.36---
Upgrade
Levered Free Cash Flow
-8.56-25.89-15.88-20.99-5.05
Upgrade
Unlevered Free Cash Flow
-8.24-25.6-15.88-20.6-4.83
Upgrade
Change in Net Working Capital
-4.213.4-1.59-2.96-3.82
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q